Factors associated with high costs of patients with metabolic dysfunction-associated steatotic liver disease: an observational study using the French CONSTANCES cohort.
Arnaud Nze OssimaAngélique BrzustowskiValérie ParadisBernard Van BeersCatherine PosticCédric LaouénanStanislas PolLaurent CastéraJean-François GautierSebastien CzernichowAnais Vallet-PichardEtienne LargerLawrence SerfatyMarie ZinsDominique VallaIsabelle Durand ZaleskiPublished in: Clinical diabetes and endocrinology (2024)
Our results emphasize the need for comprehensive management of the comorbid conditions which were the major cost drivers of MASLD.
Keyphrases